Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox. Here’s what CNBC TV’s producers were watching as chip stocks resumed their slide, and what’s on the radar for the next session. Oracle The tech giant reports after the bell on Wednesday. Oracle is up nearly 36% in the last three months. CNBC options reporter Oliver Renick reported on Tuesday that the implied move before the earnings release is 12%. That means based on past post-earnings moves, investors believe the stock could move up or down 12% after the report. Renick also reported that call buying outpaced puts 2 to 1 Tuesday. CNBC’s Seema Mody will have the numbers when they cross after the bell with the instant stock reaction. ORCL 3M mountain Oracle in the past three months The pharmaceuticals sector Jim Cramer said on “Mad Money” Tuesday night, “I like the drug stocks here.” S & P Health Care was up 1.3% Tuesday. It’s off 3.5% from the February high. S & P Pharma, Biotech and Life Sciences Industry is up 8.6% in the last month. Cramer recently bought Johnson & Johnson for his chartable trust. The stock has gained 6% since he bought it on June 1. Shares are down 6% from the high reached on March 2. The stock is up about 53% in a year. Target CNBC Fast Money Trader Guy Adami pointed out on the big show Tuesday night: Shares are up 52% from the November low. Target was up 2% on Tuesday and is now down 5% from the April 21 high. TGT 6M mountain Target shares in the past six months Italy CNBC data guru Gina Francolla and ” Morning Call ” anchor Morgan Brennan were all over Italy on Tuesday. The iShares MSCI Italy ETF (EWI) , which tracks Italy’s biggest stocks including Ferrari, defense and aerospace company Leonardo, Telecom Italia and a bunch of Italian banks, hit a new high Tuesday. EWI was up 2.5% at one point in the session, but it ended the day up just 1.5%. The ETF is up 11% in three months. Brennan will have a lot more on this ETF Wednesday on “Morning Call,” starting at 5 a.m. ET. Trulieve CNBC’s Brandon Gomez, who covers cannabis as one of his beats, will report Wednesday as Trulieve becomes the first U.S. cannabis company listed on the New York Stock Exchange. This follows recent federal changes on cannabis, potentially unlocking a lot of investor money for the industry. The stock hit a new high Tuesday morning then had a real comedown. A total bummer. Shares were down 11%. Shares are still up 24% so far in June. There are a lot of highs and lows on this one. The new ticker will be TRLV.
